Intuitive Surgical, Inc. $ISRG Shares Purchased by Pacer Advisors Inc.

Pacer Advisors Inc. lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 38.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 74,268 shares of the medical equipment provider’s stock after acquiring an additional 20,550 shares during the period. Pacer Advisors Inc.’s holdings in Intuitive Surgical were worth $34,237,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Newbridge Financial Services Group Inc. raised its stake in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the last quarter. Main Street Group LTD purchased a new stake in Intuitive Surgical in the first quarter valued at approximately $30,000. Laurel Wealth Advisors LLC acquired a new position in Intuitive Surgical in the 4th quarter worth approximately $31,000. Vermillion Wealth Management Inc. increased its holdings in Intuitive Surgical by 58.1% in the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after buying an additional 25 shares during the period. Finally, Turning Point Benefit Group Inc. raised its position in Intuitive Surgical by 833.3% during the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 50 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 6.2%

Intuitive Surgical stock opened at $375.41 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The stock’s 50 day simple moving average is $397.02 and its two-hundred day simple moving average is $449.82. The firm has a market cap of $132.62 billion, a PE ratio of 43.00, a P/E/G ratio of 2.55 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business’s revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the company earned $1.81 EPS. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Insiders Place Their Bets

In related news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the sale, the executive vice president owned 5,720 shares in the company, valued at approximately $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the transaction, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. The trade was a 46.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 6,634 shares of company stock worth $2,796,795 over the last three months. 0.60% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have commented on ISRG shares. Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, July 17th. Barclays set a $651.00 price objective on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research note on Thursday, April 23rd. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, June 13th. JPMorgan Chase & Co. decreased their target price on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating for the company in a research report on Friday, July 17th. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Twenty equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $509.02.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.